Skip to main content
Signal8

Borthwick Kathleen

SEC insider (Form 3/4/5 filer). CIK 0001987062. CFO at Passage BIO, Inc. (PASG). 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 16, 2026. Located in PHILADELPHIA, PA.

Companies Borthwick Kathleen has filed insider reports for

  • Passage BIO, Inc. (PASG): Officer, CFO
Borthwick Kathleen profile photo

Borthwick Kathleen

CIK: 0001987062

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Passage BIO, Inc. logo
PASG

Passage BIO, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Mar 16, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    15.6K shares-
  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Jan 8, 2026
    Sale
    Direct
    2.1K shares at avg. $18.44$38K
  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Jan 8, 2026
    Exercise
    Direct
    5K shares-
  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Mar 15, 2025
    Award

    Employee Stock Option (right to buy)

    Direct
    278.4K shares-
  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Feb 11, 2025
    Sale
    Direct
    3.2K shares at avg. $0.53$2K
  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Feb 10, 2025
    Exercise
    Direct
    8K shares-
  • Passage BIO, Inc. logo
    PASG

    Passage BIO, Inc.

    Jan 15, 2025
    Award

    Restricted Stock Unit

    Direct
    10K shares-

1-7 of 7